why choose us

Clinical Trials Search

Showing 18,300 of 132,963 result(s)
Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis

Status: COMPLETED

Condition: Multiple Sclerosis (MS)

Interventions:

  1. The newsletters will provide the knowledge, skills, resources, and strategies for promoting physical activity in persons newly diagnosed with

    Date: 2022-11-14

A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder

Status: Completed

Condition: Obsessive-Compulsive Disorder

Interventions: catechol-O-methyl transferase inhibitor

Date: 2022-11-14

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

Status: Completed

Condition: Diffuse Large B-Cell Lymphoma

Interventions: Oral; Tablet

Date: 2022-11-14

Nitrite Supplementation in Long COVID Patients

Status: Completed

Condition: Long COVID

Interventions: The investigators propose to study the benefits nitrite therapeutics, using nitrate-rich beetroot juice to increase serum nitrite.
The investigat

Date: 2022-11-14

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Status: Completed

Condition: Treatment Resistant Depression

Interventions: COMP360 Psilocybin administered under supportive conditions

Date: 2022-11-14

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma (CLL;SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

Status: Completed

Condition: Chronic Lymphocytic Leukemia

Interventions: 65 mg administered orally daily until disease progression, unacceptable toxicity, or discontinuation criteria met

Date: 2022-11-14

Evaluate Pharmacokinetics and Safety of Slow Release DHEA

Status: Completed

Condition: Asthma

Interventions: DHEA is a hormone produced by the body's adrenal gland.
In drug form, it is available as an over-the-counter supplement that is available on

Date: 2022-11-14

TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality

Status: Completed

Condition: Rhinosinusitis Chronic

Interventions: Within 10 minutes of general anesthetic induction, 15mg;kg TXA suspended in 100mL of normal saline will be administered intravenously.

Date: 2022-11-14

Microwave Treatment for Actinic Keratosis

Status: Completed

Condition: Keratosis, Actinic

Interventions:

Localized microwave energy applied to the distinct AK lesion.
Each subject will receive treatment for a maximum of 2 visits (4-week interval b

Date: 2022-11-14

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

Status: Completed

Condition: Acneiform Eruption Due to Chemical

Interventions: Topical gel, 2% active

Date: 2022-11-14